February was a tough month for biotech stocks researching stem cells for the treatment and cure of diseases. TickerSpy’s Stem Cell Stocks Index (RXSTM) has slipped nearly 13% since early February being outperformed by the S&P 500 by close to 17% during that time.
Four particular stem cell stocks, all cheap stocks under 5 including 2 penny stocks, should ...
Continue Reading →
5
MAR
MAR
0
Share
